Latest Natalizumab Stories
ProgressiveMultifocalLeukoencephalopathy.org aims to assist individuals in learning about PML. (PRWEB) November 28, 2011 Flood Law Group, LLP, a litigation
Taking the new generation anti-inflammatory drug natalizumab for two years lowers the number of remitting multiple sclerosis patients who experience relapses and progression of disability.
Biopharma intelligence provider will also moderate live panel on funding biopharma innovation at Prix Galien USA on September 27 in NYC. Norwood, MA (PRWEB)
ATLANTA, Aug. 16, 2011 /PRNewswire/ -- Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001.
- totally perplexed and mixed up.